BioSpace News Archive

ESCAPE Bio Inc., a clinical stage company developing novel, precisely targeted therapeutics for genetic neurodegenerative diseases, today announced that Paul Wren, Ph.D., Chief Scientific Officer of ESCAPE Bio, will participate in a fireside chat at Stifel’s 3rd Annual CNS Day on Thursday, April 1, 2021, at 3:30 p.m. ET

B. Braun Interventional Systems Inc. (BIS) announced today that they will collaborate with Infraredx, a Nipro Company, to accelerate the U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) clinical trial for the B. Braun SeQuent® Please ReX™ Drug Coated PTCA Balloon Catheter, which received FDA Breakthrough Device Designation in late 2019

CDISC announced a collaboration with A3 Informatics to create industry-standard Biomedical Concepts with the goal of supporting their awareness and encouraging their adoption in clinical research

Advances Phase 1/1b Study of APVO436 for Treatment of Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome; Enrollment in Cohort 10 Ongoing Completes Sale of RUXIENCE Royalty Payments for Up Front Plus Milestone Payments of up to $67.5 million; Amends Non-Dilutive Term Loan Agreement

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Wednesday, April 14.

EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strains—including all flu pandemics.

TORONTO, March 31, 2021 /PRNewswire/ - Kontrol Technologies Corp. is pleased to provide an update on its manufacturing capacity as it relates to various milestones for the Ontario Together Fund.

BioLargo, Inc., a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Annual Report on Form 10-K with the SEC for the year ended December 31, 2020.

US Digestive Health, a management services organization established to expand access to high-quality, low-cost gastroenterology care, announced the addition of Brad Stoltz as Chief Operating Officer for the fast-growing organization.

KeifeRx, LLC, an emerging clinical-stage biotechnology company specializing in the discovery and development of new treatment options for neurodegenerative diseases, announced today that Chris Hoyt, former Co-Founder and CFO of Upskill Inc., has been appointed to serve as Chief Executive Officer.